A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis

NCT06335888 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Giant Cell Arteritis

Interventions

DRUG: AzaFol
DRUG: FDG

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators

[object Object]